Cargando…

S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Detalles Bibliográficos
Autores principales: Mateos, Maria-Victoria, Morillo, Daniel, Gatt, Moshe, Sebag, Michael, Kim, Kihyun, Min, Chang-Ki, Oriol, Albert, Ocio, Enrique, Yoon, Sung-Soo, Cohen, Yael, Chu, Michael, Rodríguez-Otero, Paula, Avivi, Irit, Guo, Yue, Krevvata, Maria, Peterson, Michelle, Beelen, Melissa, Vanak, Jill, Banerjee, Arnob, Magen, Hila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/
http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7
_version_ 1785090466612510720
author Mateos, Maria-Victoria
Morillo, Daniel
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Oriol, Albert
Ocio, Enrique
Yoon, Sung-Soo
Cohen, Yael
Chu, Michael
Rodríguez-Otero, Paula
Avivi, Irit
Guo, Yue
Krevvata, Maria
Peterson, Michelle
Beelen, Melissa
Vanak, Jill
Banerjee, Arnob
Magen, Hila
author_facet Mateos, Maria-Victoria
Morillo, Daniel
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Oriol, Albert
Ocio, Enrique
Yoon, Sung-Soo
Cohen, Yael
Chu, Michael
Rodríguez-Otero, Paula
Avivi, Irit
Guo, Yue
Krevvata, Maria
Peterson, Michelle
Beelen, Melissa
Vanak, Jill
Banerjee, Arnob
Magen, Hila
author_sort Mateos, Maria-Victoria
collection PubMed
description
format Online
Article
Text
id pubmed-10428427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284272023-08-17 S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) Mateos, Maria-Victoria Morillo, Daniel Gatt, Moshe Sebag, Michael Kim, Kihyun Min, Chang-Ki Oriol, Albert Ocio, Enrique Yoon, Sung-Soo Cohen, Yael Chu, Michael Rodríguez-Otero, Paula Avivi, Irit Guo, Yue Krevvata, Maria Peterson, Michelle Beelen, Melissa Vanak, Jill Banerjee, Arnob Magen, Hila Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428427/ http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Mateos, Maria-Victoria
Morillo, Daniel
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Oriol, Albert
Ocio, Enrique
Yoon, Sung-Soo
Cohen, Yael
Chu, Michael
Rodríguez-Otero, Paula
Avivi, Irit
Guo, Yue
Krevvata, Maria
Peterson, Michelle
Beelen, Melissa
Vanak, Jill
Banerjee, Arnob
Magen, Hila
S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_fullStr S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full_unstemmed S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_short S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_sort s190: first results from the redirectt-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting bcma and gprc5d in patients (pts) with relapsed/refractory multiple myeloma (rrmm)
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/
http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7
work_keys_str_mv AT mateosmariavictoria s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT morillodaniel s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT gattmoshe s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT sebagmichael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT kimkihyun s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT minchangki s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT oriolalbert s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT ocioenrique s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT yoonsungsoo s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT cohenyael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT chumichael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT rodriguezoteropaula s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT aviviirit s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT guoyue s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT krevvatamaria s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT petersonmichelle s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT beelenmelissa s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT vanakjill s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT banerjeearnob s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm
AT magenhila s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm